Zealand Pharma A/S - Product Pipeline Review - 2016

  • ID: 3720450
  • Company Profile
  • 37 pages
  • Global Markets Direct
1 of 4
Zealand Pharma A/S - Product Pipeline Review - 2016

Summary

‘Zealand Pharma A/S - Product Pipeline Review - 2016’, provides an overview of the Zealand Pharma A/S’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Zealand Pharma A/S, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Our report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Zealand Pharma A/S
- The report provides overview of Zealand Pharma A/S including its business description, key facts, and locations and subsidiaries
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report assesses Zealand Pharma A/S’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
- The report features Zealand Pharma A/S’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

- Evaluate Zealand Pharma A/S’s strategic position with total access to detailed information on its product pipeline
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of therapeutics under development for Zealand Pharma A/S
- Identify potential new clients or partners in the target demographic
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Zealand Pharma A/S’s pipeline depth and focus of pipeline therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
READ MORE
Note: Product cover images may vary from those shown
2 of 4
List of Tables

List of Figures

Zealand Pharma A/S Snapshot

Zealand Pharma A/S Overview

Key Information

Key Facts

Zealand Pharma A/S - Research and Development Overview

Key Therapeutic Areas

Zealand Pharma A/S - Pipeline Review

Pipeline Products by Stage of Development

Pipeline Products - Monotherapy

Pipeline Products - Partnered Products

Partnered Products/Combination Treatment Modalities

Pipeline Products - Out-Licensed Products

Out-Licensed Products/Combination Treatment Modalities

Zealand Pharma A/S - Pipeline Products Glance

Zealand Pharma A/S - Clinical Stage Pipeline Products

Phase II Products/Combination Treatment Modalities

Phase I Products/Combination Treatment Modalities

Zealand Pharma A/S - Early Stage Pipeline Products

Preclinical Products/Combination Treatment Modalities

Zealand Pharma A/S - Drug Profiles

ZP-1848

Product Description

Mechanism of Action

R&D Progress

ZP-4207

Product Description

Mechanism of Action

R&D Progress

ZP-2929

Product Description

Mechanism of Action

R&D Progress

Synthetic Peptide for Diabetes and Obesity

Product Description

Mechanism of Action

R&D Progress

Synthetic Peptides for Undisclosed Indications

Product Description

Mechanism of Action

R&D Progress

ZP-3022

Product Description

Mechanism of Action

R&D Progress

ZPDI-70

Product Description

Mechanism of Action

R&D Progress

ZPGG-23

Product Description

Mechanism of Action

R&D Progress

ZPGG-72

Product Description

Mechanism of Action

R&D Progress

ZPI-98

Product Description

Mechanism of Action

R&D Progress

Zealand Pharma A/S - Pipeline Analysis

Zealand Pharma A/S - Pipeline Products by Target

Zealand Pharma A/S - Pipeline Products by Route of Administration

Zealand Pharma A/S - Pipeline Products by Molecule Type

Zealand Pharma A/S - Pipeline Products by Mechanism of Action

Zealand Pharma A/S - Recent Pipeline Updates

Zealand Pharma A/S - Dormant Projects

Zealand Pharma A/S - Locations And Subsidiaries

Head Office

Appendix

Methodology

Coverage

Secondary Research

Primary Research

Expert Panel Validation

Contact Us

Disclaimer

List of Tables

Zealand Pharma A/S, Key Information

Zealand Pharma A/S, Key Facts

Zealand Pharma A/S - Pipeline by Indication, 2016

Zealand Pharma A/S - Pipeline by Stage of Development, 2016

Zealand Pharma A/S - Monotherapy Products in Pipeline, 2016

Zealand Pharma A/S - Partnered Products in Pipeline, 2016

Zealand Pharma A/S - Partnered Products/ Combination Treatment Modalities, 2016

Zealand Pharma A/S - Out-Licensed Products in Pipeline, 2016

Zealand Pharma A/S - Out-Licensed Products/ Combination Treatment Modalities, 2016

Zealand Pharma A/S - Phase II, 2016

Zealand Pharma A/S - Phase I, 2016

Zealand Pharma A/S - Preclinical, 2016

Zealand Pharma A/S - Pipeline by Target, 2016

Zealand Pharma A/S - Pipeline by Route of Administration, 2016

Zealand Pharma A/S - Pipeline by Molecule Type, 2016

Zealand Pharma A/S - Pipeline Products by Mechanism of Action, 2016

Zealand Pharma A/S - Recent Pipeline Updates, 2016

Zealand Pharma A/S - Dormant Developmental Projects,2016

List of Figures

Zealand Pharma A/S - Pipeline by Indication, 2016

Zealand Pharma A/S - Pipeline by Stage of Development, 2016

Zealand Pharma A/S - Monotherapy Products in Pipeline, 2016

Zealand Pharma A/S - Partnered Products in Pipeline, 2016

Zealand Pharma A/S - Out-Licensed Products in Pipeline, 2016

Zealand Pharma A/S - Pipeline by Target, 2016

Zealand Pharma A/S - Pipeline by Route of Administration, 2016

Zealand Pharma A/S - Pipeline by Molecule Type, 2016

Zealand Pharma A/S - Pipeline Products by Mechanism of Action, 2016
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll